| Not Yet Recruiting | A Randomized Controlled Study Comparing the Safety and Efficacy of Irinotecan Hydrochloride Liposome Injection NCT07092306 | Tang Xiaodong | Phase 2 |
| Active Not Recruiting | A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in NCT04671693 | Centre Leon Berard | N/A |
| Completed | Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 NCT02890758 | Brenda Cooper, MD | Phase 1 |
| Recruiting | Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas NCT03442465 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma NCT02736565 | Gradalis, Inc. | Phase 1 |
| Withdrawn | Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors NCT02689336 | Washington University School of Medicine | Phase 2 |
| Completed | A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in NCT02511132 | Gradalis, Inc. | Phase 2 |
| Completed | Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With NCT01962103 | Celgene | Phase 1 / Phase 2 |
| Withdrawn | Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients NCT01734863 | Children's Cancer Hospital Egypt 57357 | Phase 3 |
| Completed | Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy NCT01674101 | St. Jude Children's Research Hospital | N/A |
| Completed | Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma NCT01583543 | Massachusetts General Hospital | Phase 2 |
| Completed | Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI NCT01336803 | Heike E Daldrup-Link | Phase 2 |
| Terminated | Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma NCT01313884 | Stanford University | Phase 2 |
| Completed | Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors NCT01331135 | Emory University | Phase 1 |
| Completed | Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides NCT01598454 | Laboratorio Elea Phoenix S.A. | Phase 1 |
| Completed | Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of NCT01222767 | PharmaMar | Phase 2 |
| Completed | Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients NCT01169584 | Jennerex Biotherapeutics | Phase 1 |
| Completed | Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adult NCT01696669 | Grupo Espanol de Investigacion en Sarcomas | Phase 2 |
| Completed | Study in Localized and Disseminated Ewing Sarcoma NCT00987636 | University Hospital Muenster | Phase 3 |
| Completed | Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma NCT02063022 | Italian Sarcoma Group | Phase 3 |
| Completed | Informed Consent in Pediatric Cancer Trials NCT00923650 | National Cancer Institute (NCI) | — |
| Completed | QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small NCT00563680 | NantCell, Inc. | Phase 2 |
| Terminated | Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT) NCT00568464 | Fudan University | Phase 2 |
| Terminated | HGS-ETR2 to Treat Children With Solid Tumors NCT00428272 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Aerosol L9-NC and Temozolomide in Ewing's Sarcoma NCT00492141 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Unknown | Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's NCT00541411 | King Faisal Specialist Hospital & Research Center | N/A |
| Completed | Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy NCT00004853 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors NCT00179816 | Ann & Robert H Lurie Children's Hospital of Chicago | Phase 1 / Phase 2 |
| Completed | Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases NCT00001686 | National Cancer Institute (NCI) | — |
| Terminated | Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients NCT00038142 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation NCT00001564 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After NCT00001566 | National Cancer Institute (NCI) | Phase 2 |
| Completed | New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and NCT00001335 | National Cancer Institute (NCI) | Phase 2 |